INKON Life Technology Co., Ltd. (SHE:300143)

China flag China · Delayed Price · Currency is CNY
7.58
-0.30 (-3.81%)
At close: Jun 4, 2026
Market Cap7.34B +3.4%
Revenue (ttm)1.97B +27.1%
Net Income64.31M -46.0%
EPS0.06 -52.9%
Shares Out 968.41M
PE Ratio116.87
Forward PEn/a
Dividend0.02 (0.24%)
Ex-Dividend DateJun 3, 2026
Volume8,922,999
Open7.87
Previous Close7.88
Day's Range7.50 - 7.87
52-Week Range6.97 - 11.06
Beta0.40
Analystsn/a
Price Targetn/a
Earnings DateAug 26, 2026

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology... [Read more]

Sector Healthcare
Founded 1998
Employees 2,662
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300143
Full Company Profile

Financial Performance

In 2025, INKON Life Technology's revenue was 1.89 billion, an increase of 20.93% compared to the previous year's 1.56 billion. Earnings were 68.54 million, a decrease of -40.62%.

Financial Statements